Gas-Grain Simulation Facility: Fundamental studies of particle formation and interactions. Volume 2: Abstracts, candidate experiments and feasibility study

An overview of the Gas-Grain Simulation Facility (GGSF) project and its current status is provided. The proceedings of the Gas-Grain Simulation Facility Experiments Workshop are recorded. The goal of the workshop was to define experiments for the GGSF--a small particle microgravity research facility. The workshop addressed the opportunity for performing, in Earth orbit, a wide variety of experiments that involve single small particles (grains) or clouds of particles. Twenty experiments from the fields of exobiology, planetary science, astrophysics, atmospheric science, biology, physics, and chemistry were described at the workshop and are outlined in Volume 2. Each experiment description included specific scientific objectives, an outline of the experimental procedure, and the anticipated GGSF performance requirements. Since these experiments represent the types of studies that will ultimately be proposed for the facility, they will be used to define the general science requirements of the GGSF. Also included in the second volume is a physics feasibility study and abstracts of example Gas-Grain Simulation Facility experiments and related experiments in progress

Gas-Grain Simulation Facility: Fundamental studies of particle formation and interactions. Volume 1: Executive summary and overview

An overview of the Gas-Grain Simulation Facility (GGSF) project and its current status is provided. The proceedings of the Gas-Grain Simulation Facility Experiments Workshop are recorded. The goal of the workshop was to define experiments for the GGSF--a small particle microgravity research facility. The workshop addressed the opportunity for performing, in Earth orbit, a wide variety of experiments that involve single small particles (grains) or clouds of particles. The first volume includes the executive summary, overview, scientific justification, history, and planned development of the Facility

Space Station Gas-Grain Simulation Facility: Microgravity Particle Research

A wide variety of experiments significant to Exobiology, Planetary Science, Astrophysics, Atmospheric Science, and basic Chemistry and Physics involves the physical interactions of small particles (micrometer to centimeter in size). In many astro-geophysical systems (atmospheric clouds, interstellar clouds, planetary rings, Titan\u27s organic aerosols, Martian dust storms, lightning, etc.), processes involving small particles determine the overall behavior of the system. Condensation of particles from a gas, aggregation of small particles into larger ones, low velocity collisions, and charge accumulation are a few of the processes that influence particles in these systems. Examples of particles undergoing these processes include interstellar grains, protoplanetary particles, atmospheric aerosols, combustion products, and abiotic organic polymers. Although processes of the type described above span a wide range of disciplines, the study of these processes places common fundamental constraints on particle handling. Two common constraints are the need for long time periods during which the particles must be suspended and low relative velocities between particles. Experiments involving small particles generally require material be suspended for periods substantially longer than are practical in Earth\u27s 1 g gravitational field. However, one can investigate these processes with a general-purpose particle research facility (in particular, with the proposed Gas-Grain Simulation Facility) on the Space Station 1 \u273 . Because of the very low gravitational acceleration (microgravity) in the Earth orbital environment, many experiments deemed impractical or impossible to perform on Earth will become feasible. Such experiments are those in which gravity either interferes directly with the phenomenon under study (e.g., gravitational convection masks diffusional processes) or in which gravity precludes the establishment of the proper experimental conditions (e.g., in 1 g, gravity accelerates test objects to unacceptable velocities)

Gas-grain simulation facility: Aerosol and particle research in microgravity

This document reports on the proceedings of the Gas-Grain Simulation Facility (GGSF) Science Workshop which was co-hosted by NASA Ames Research Center and Desert Research Institute, University of Nevada System, and held in Las Vegas, Nevada, on May 4-6, 1992. The intent of the workshop was to bring together the science community of potential GGSF experimenters, Science Working Group and staff members, and the Phase A contractor to review the Phase A design with the science participants and to facilitate communication between the science community and the hardware developers. The purpose of this report is to document the information disseminated at the workshop, to record the participants' review of the Phase A GGSF design concept and the current science and technical requirements for the Facility, and to respond to any questions or concerns that were raised at the Workshop. Recommendations for the future based on numerous discussions with the participants are documented, as well as science presentations and poster sessions that were given at the Workshop and a summary of 21 candidate experiments

Exobiology in Solar System Exploration

A symposium, 'Exobiology in Solar System Exploration,' was held on 24-26 Aug. 1988. The symposium provided an in-depth investigation of the role of Exobiology in solar system exploration. It is expected that the symposium will provide direction for future participation of the Exobiology community in solar system exploration and alert the Planetary community to the continued importance of an Exobiology Flight Program. Although the focus of the symposium was primarily on Exobiology in solar system exploration missions, several ground based and Earth-orbital projects such as the Search for Extraterrestrial Intelligence, Gas Grain Facility, and Cosmic Dust Collection Facility represent upcoming research opportunities planned to accommodate the goals and objectives of the Exobiology community as well. This report contains papers for all but one of the presentations given at the symposium

Efficacy of ceftolozane/tazobactam against urinary tract and intra-abdominal infections caused by ESBL-producing Escherichia coli and Klebsiella pneumoniae: a pooled analysis of Phase 3 clinical trials

The increase in infections caused by drug-resistant ESBL-producing Enterobacteriaceae (ESBL-ENT) is a global concern. The characteristics and outcomes of patients infected with ESBL-ENT were examined in a pooled analysis of Phase 3 clinical trials of ceftolozane/tazobactam in patients with complicated urinary tract infections (ASPECT-cUTI) and complicated intra-abdominal infections (ASPECT-cIAI).Trials were randomized and double blind. The ASPECT-cUTI regimen was 7 days of either intravenous ceftolozane/tazobactam (1.5 g) every 8 h or levofloxacin (750 mg) once daily. The ASPECT-cIAI regimen was 4-14 days of either intravenous ceftolozane/tazobactam (1.5 g) plus metronidazole (500 mg) or meropenem (1 g) every 8 h. Baseline cultures were obtained in both indications. Enterobacteriaceae were selected for ESBL characterization based on predefined criteria and were verified genotypically. Outcomes were assessed at the test-of-cure visit 5-9 days post-therapy in ASPECT-cUTI and 24-32 days post-randomization in ASPECT-cIAI among microbiologically evaluable (ME) patients.Of 2076 patients randomized, 1346 were included in the pooled ME population and 150 of 1346 (11.1%) had ESBL-ENT at baseline. At US FDA/EUCAST breakpoints of ≤2/≤1 mg/L, 81.8%/72.3% of ESBL-ENT (ESBL-Escherichia coli, 95%/88.1%; ESBL-Klebsiella pneumoniae, 56.7%/36.7%) were susceptible to ceftolozane/tazobactam versus 25.3%/24.1% susceptible to levofloxacin and 98.3%/98.3% susceptible to meropenem at CLSI/EUCAST breakpoints. Clinical cure rates for ME patients with ESBL-ENT were 97.4% (76/78) for ceftolozane/tazobactam [ESBL-E. coli, 98.0% (49 of 50); ESBL-K. pneumoniae, 94.4% (17 of 18)], 82.6% (38 of 46) for levofloxacin and 88.5% (23 of 26) for meropenem.Randomized trial data demonstrated high clinical cure rates with ceftolozane/tazobactam treatment of cIAI and cUTI caused by ESBL-ENT

A Search for Fractional Charges in Native Mercury

We have searched 2.0 mg of native mercury for fractional charges. Details of the apparatus and measurement procedure are presented. We find no fractional charges, giving a limit on quark concentration comparable to other experiments carried out on refined materials